There are 12 defendants in the case, including former Chairman of the Board of Directors of the Vietnam National Oil and Gas Group (PetroVietnam) Dinh La Thang; former Chairman of the Board of Directors and former General Director of the PetroVietnam Construction JSC (PVC) Trinh Xuan Thanh; and several former executives of PetroVietnam, PVC and the PetroVietnam PetroChemicals and Biofuel JSC (PVB).
Trinh Xuan Thanh has been charged with “violating regulations on investment in construction works, causing serious consequences” under Article 224, Clause 3 of the Penal Code 2015, and “abusing position and power while performing duties” under Article 356, Clause 3.
Thang, meanwhile, has been accused of “violating regulations on investment in construction works, causing serious consequences.”
A total of 31 lawyers will represent the defendants during the 10-day trial.
According to the indictment, Thang signed a resolution to approve the investment in the Phu Tho ethanol project in October 2007. With Thanh’s support, PVC/Alfa Laval/Delta-T joint contractors, who had no previous experience in carrying out ethanol projects, were assigned to be in charge of the project.
As a result, the project was continuously behind schedule and stopped in March 2013 with no construction items done.
Wrongdoings of the defendants were said to cause a loss of more than VND543 billion (US$23.49 million ).
Other news

HCMC police handling case of money appropriation from company in Dubai

Obstetrician nabbed for involving in illegal surrogacy ring in Hanoi

Quang Tri Province’s Police detect three illegal Chinese immigrants

Traffic police detect more than 13,000 drunk drivers

Strict punishment on case of community warden beating two boys at school ordered

District 10 informs case of community warden beating two teenagers at school

Six people in drug trafficking ring in Hanoi's mental hospital prosecuted

Flight attendant receives two-year probation for spreading dangerous disease

Police detect nearly 10,000 drivers violating blood alcohol, drug content
